The Vaccine and Infectious Disease Division, VIDD, was established by the Fred Hutchinson Cancer Research Center, first as an Institute in 2007 and as a Scientific Division of the Center in 2010, to address the growing need for treatment and prevention strategies for infectious diseases worldwide.  By integrating biometric, laboratory, and clinical science, the researchers at VIDD aim to develop novel vaccines for infectious diseases that threaten global health, to shed light on the workings of the human immune system, and to develop novel treatment and prevention strategies to lessen the burden of infectious diseases and cancers caused by infection, particularly in the immunocompromised host. 

VIDD is composed of three research groups: Population Sciences, including the Statistical Center for HIV and AIDS Research and Prevention (SCHARP), led by Dr. Steve Self; Infectious Disease Sciences, led by Dr. Larry Corey; and Immunology and Vaccine Development, led by Dr. Julie McElrath.  In addition, the international HIV Vaccine Trials Network (HVTN) is headquartered at VIDD.

VIDD provides a unique environment for career development in the areas of infectious disease research, vaccine development and the role of infectious agents in cancer. VIDD’s 27 faculty members also hold appointments in either the Clinical Research or Public Health Sciences Division at the Center.  VIDD also includes 21 affiliate investigators, mainly from the University of Washington.

For more, see About VIDD

	About VIDD
	Programs
	Leadership
	Faculty
	Events
	VIDD in the News
	Related Links
	Contact Info
	VIDD Newsletter